[HTML][HTML] Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance …

JA Ligibel, WT Barry, C Alfano, DL Hershman… - NPJ breast …, 2017 - nature.com
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study …

JA Ligibel, WT Barry, C Alfano… - npj Breast …, 2017 - ohiostate.elsevierpure.com
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

[HTML][HTML] Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance …

JA Ligibel, WT Barry, C Alfano, DL Hershman… - NPJ Breast …, 2017 - ncbi.nlm.nih.gov
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study …

JA Ligibel, WT Barry, C Alfano… - NPJ Breast …, 2017 - search.proquest.com
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study …

JA Ligibel, WT Barry, C Alfano… - NPJ Breast …, 2017 - search.ebscohost.com
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study …

JA Ligibel, WT Barry, C Alfano… - NPJ breast …, 2017 - pubmed.ncbi.nlm.nih.gov
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study …

JA Ligibel, WT Barry, C Alfano… - npj Breast …, 2017 - pure.johnshopkins.edu
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study …

JA Ligibel, WT Barry, C Alfano, DL Hershman… - NPJ Breast …, 2017 - europepmc.org
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study …

JA Ligibel, WT Barry, C Alfano, DL Hershman… - NPJ Breast …, 2017 - europepmc.org
Excess body weight is a poor prognostic factor in women with early breast cancer, but the
effect of weight loss on the risk of breast cancer recurrence and mortality in women who are …